Z17 ICD-10-CM Code: Estrogen, and other hormones and factors receptor status
Billing Status: NO. This is a clinician non-billable / parent hierarchy grouping in the ICD-10-CM system.
Coding at a Glance
- Tabular directives
- 3 code-first instructions
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for Z17 in the official ICD-10-CM tabular list, quoted as published.
Source: CMS/CDC — ICD-10-CM Tabular ListRelease: FY2026Effective: October 1, 2025
Coder workflow for Z17
MedCoder structured workflow — derived from this code’s own official record
Before you code Z17
- Z17 is not reportable as written. Select the more specific code beneath it that the documentation supports. Codes are reported to the highest level of specificity the classification provides (Guidelines I.B.2).
ReviewZ17.0, Z17.1, Z17.2, Z17.3, Z17.4
See the relationships section · Guide: How to choose an ICD-10-CM code →
- Confirm the reason for the encounter this Z code records: the circumstance it records. Check whether the code may be reported as first-listed or principal — some Z codes are limited to one position — and do not report a history or status code for a condition documented as current. Z code categories and their reporting positions (Guidelines I.C.21.c, I.C.21.c.15).
Choose the right path
- Does the documentation support one of the more specific codes beneath Z17?
Yes → Select that code and continue the checks below on its own page.
No → Z17 cannot be reported as written; query for the specificity its subcategory needs. - Is the underlying (etiologic) condition the Code First note names documented?
Yes → Sequence the underlying condition first, then Z17.
No → Continue; do not add an underlying condition the record does not document.
Consider Z17. Then confirm the code is valid for the date of service in the Verify section.
Documentation check
- The provider’s diagnostic statement
- Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
- The underlying (etiologic) condition
- Named in the Code First note; sequenced before this code when documented (Guidelines I.A.13).
- The reason for the encounter
- Whether the code records the encounter’s purpose, a status, or a history — and whether it may be first-listed (Guidelines I.C.21.c).
Official instructions as workflow
Code First — sequencing check(3 notes)
Coding workflow: Check whether the underlying or etiologic condition the note names is documented. When it is, sequence it before Z17. Do not add an underlying condition the record does not document.
See the official tabular notes · Guidelines I.A.13
Coding decision scenarios
Pattern scenarios for this code’s structure — decision rules, not clinical cases
Documentation: The underlying condition the Code First note names is documented alongside this condition.
Coding question: How are the two sequenced?
Path: Review the Code First note.
Reason: The underlying condition is sequenced first and the manifestation follows (Guidelines I.A.13).
Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Official Coding Guidelines
Official source data — quoted verbatim from the CMS/NCHS Official Guidelines
Official source data — quoted verbatim from the CMS/NCHS Official Guidelines
Verbatim excerpts from the ICD-10-CM Official Guidelines for Coding and Reporting (CMS/NCHS) that govern this code.
Chapter 21: Factors influencing health status and contact with health services (Z00-Z99)
Codes from category Z15 should generally not be used as principal or first-listed codes. If the patient has the condition to which he/she is susceptible, and that condition is the reason for the encounter, the code for the current condition should be sequenced first. If the patient is being seen for follow-up after completed treatment for this condition, and the condition no longer exists, a follow-up code should be sequenced first, followed by the appropriate personal history and genetic susceptibility codes. If the purpose of the encounter is genetic counseling associated with procreative management, code Z31.5, Encounter for genetic counseling, should be assigned as the first-listed code, followed by a code from category Z15. Additional codes should be assigned for any applicable family or personal history. Z16 Resistance to antimicrobial drugs This category indicates that a patient has a condition that is resistant to antimicrobial drug treatment. Sequence the infection code first. Z17 Estrogen, and other hormones and factors receptor status Z18 Retained foreign body fragments Z19 Hormone sensitivity malignancy status Z21 Asymptomatic HIV infection status This code indicates that a patient has tested positive for HIV but has manifested no signs or symptoms of the disease. Z22 Carrier of infectious disease Carrier status indicates that a person harbors the specific organisms of a disease without manifest symptoms and is capable of transmitting the infection. Z28.3 Underimmunization status
Verify Before Coding
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder structured relationships — computed from published CMS and AHRQ datasets
Other codes that name Z17 or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.
Referenced by 1 Use Additional Code instruction: C50 — Malignant neoplasm of breast.
These codes instruct coders to additionally report this code when it applies.
Contextual Map
Every relationship of Z17 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run Z17 with these 2 related codes in Claim Check
Hierarchy
- Z00-Z99 — Chapter 21: Factors Influencing Health Status and Contact with Health Services (Z00-Z99) (Z00-Z99)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17-Z17 — Estrogen, and other hormones and factors receptor status[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
Code First
- C50 — Malignant neoplasm of breast[Code First]: “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- C56 — Malignant neoplasm of ovary[Code First]: “malignant neoplasm of ovary (C56.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Referenced by Use Additional Code instructions
- C50 — Malignant neoplasm of breast[Use Additional Code]: “code to identify estrogen, and other hormones and factors receptor status (Z17.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Nearest codes (15)
- Z17.0 — Estrogen receptor positive status [ER+][Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.1 — Estrogen receptor negative status [ER-][Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.2 — Progesterone receptor status[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.21 — Progesterone receptor positive status[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.22 — Progesterone receptor negative status[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.3 — Human epidermal growth factor 2 receptor[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.31 — Human epidermal growth factor receptor 2 positive status[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z17.32 — Human epidermal growth factor receptor 2 negative status[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- and 7 more
Change history (3)
- FY2025 — Description revised[Change history]— CMS release files (code change ledger) · icd10cm-fy2025
- and 2 more
Common coding questions
Can Z17 be billed directly?
No. Z17 (Estrogen, and other hormones and factors receptor status) is a non-billable ICD-10-CM category code. A more specific billable subcode must be selected based on clinical documentation.
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2026 tabular list, index and tables, effective October 1, 2025 Release, file and checksum · Publisher’s page
- Coding guidelines Official source data
- ICD-10-CM Official Guidelines for Coding and Reporting (FY2026), quoted by section Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v43.1 (April 2026) Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "Z17 — Estrogen, and other hormones and factors receptor status." ICD-10-CM FY2026. https://medcoder.ai/icd10/code/z17-estrogen-and-other-hormones-and-factors-receptor-status
Change history
- FY2025 — October 1, 2024Description revisedEstrogen receptor status → Estrogen, and other hormones and factors receptor statusFY2025 changes
- FY2025 — October 1, 2024Short description revisedEstrogen receptor status → Estrogen, and other hormones and factors receptor statusFY2025 changes
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionEstrogen receptor status
Nearest Codes in This Family
Official ICD-10-CM classifications closest to Z17 in its code family, with their registry titles.
- Z17.0 — Estrogen receptor positive status [ER+]
- Z17.1 — Estrogen receptor negative status [ER-]
- Z17.2 — Progesterone receptor status
- Z17.21 — Progesterone receptor positive status
- Z17.22 — Progesterone receptor negative status
- Z17.3 — Human epidermal growth factor 2 receptor
- Z17.31 — Human epidermal growth factor receptor 2 positive status
- Z17.32 — Human epidermal growth factor receptor 2 negative status
- Z17.4 — Combined receptor status
- Z17.41 — Hormone receptor positive
- Z17.410 — Hormone receptor positive with human epidermal growth factor receptor 2 positive status
- Z17.411 — Hormone receptor positive with human epidermal growth factor receptor 2 negative status
- Z17.42 — Hormone receptor negative
- Z17.420 — Hormone receptor negative with human epidermal growth factor receptor 2 positive status
- Z17.421 — Hormone receptor negative with human epidermal growth factor receptor 2 negative status